Limitation of life‑sustaining therapies in critically ill patients with COVID‑19: What lessons to draw?
- PMID: 37218008
- PMCID: PMC10201470
- DOI: 10.1186/s13054-023-04470-1
Limitation of life‑sustaining therapies in critically ill patients with COVID‑19: What lessons to draw?
Keywords: COVID-19; Ethical consulting units; Ethics; Limitation of life-sustaining therapies; Pandemic.
Conflict of interest statement
The authors declare that they have no competing interests.
Comment on
-
Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study.Crit Care. 2023 Mar 11;27(1):103. doi: 10.1186/s13054-023-04349-1. Crit Care. 2023. PMID: 36906643 Free PMC article.
References
-
- Giabicani M, Le Terrier C, Poncet A, Guidet B, Rigaud JP, Quenot JP, et al. Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study. Crit Care. 2023;27:103. doi: 10.1186/s13054-023-04349-1. - DOI - PMC - PubMed
-
- Lai AG, Pasea L, Banerjee A, Hall G, Denaxas S, Chang WH, et al. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open. 2020;10:e043828. doi: 10.1136/bmjopen-2020-043828. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical